erlotinib hydrochloride has been researched along with triamcinolone acetonide in 1 studies
Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (triamcinolone acetonide) | Trials (triamcinolone acetonide) | Recent Studies (post-2010) (triamcinolone acetonide) |
---|---|---|---|---|---|
4,353 | 786 | 3,033 | 6,188 | 1,017 | 1,609 |
Protein | Taxonomy | erlotinib hydrochloride (IC50) | triamcinolone acetonide (IC50) |
---|---|---|---|
Glucocorticoid receptor | Homo sapiens (human) | 0.0044 | |
Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.0044 | |
Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.0044 | |
Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.0044 | |
Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.0044 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Almeida, DR; Boldt, HC; Chin, EK; Hornick, AL; Kirkpatrick, CA | 1 |
1 other study(ies) available for erlotinib hydrochloride and triamcinolone acetonide
Article | Year |
---|---|
Erlotinib-associated bilateral anterior uveitis: resolution with posterior sub-Tenon's triamcinolone without erlotinib cessation.
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Erlotinib Hydrochloride; Female; Glucocorticoids; Humans; Liver Neoplasms; Lung Neoplasms; Neoplasm Staging; Tenon Capsule; Triamcinolone Acetonide; Uveitis, Anterior | 2015 |